Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026)

Ocular Therapeutix's Other Operating Expenses history runs 14 years deep, the most recent figure standing at $17.9 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 16.2% year-over-year to $17.9 million; the TTM figure through Mar 2026 stood at $63.0 million (up 23.23% YoY), while the FY2025 annual figure was $60.5 million, up 28.13% from the prior year.
• Other Operating Expenses was $17.9 million for Q1 2026 at Ocular Therapeutix, up from $14.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $17.9 million in Q1 2026 to a low of $10.4 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $12.7 million across 5 years, with a median of $12.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses slipped 7.91% in 2023, then surged 36.25% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $11.5 million in 2022, then dropped by 7.91% to $10.6 million in 2023, then advanced by 13.54% to $12.1 million in 2024, then grew by 20.56% to $14.6 million in 2025, then climbed by 23.06% to $17.9 million in 2026.
• The last three Other Operating Expenses figures came in at $17.9 million (Q1 2026), $14.6 million (Q4 2025), and $14.9 million (Q3 2025), per Business Quant data.